Other Information
−Removed: Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Advanced Conceptions, Inc., and Richard Abbott, as Company Representative (Incorporated by reference herein from Form 8-K (Exhibit 2.1), filed 06/16/22, SEC File No.
−Removed: Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Idaho Molecular, Inc., and Kirk Ririe, as Company Representative (Incorporated by reference herein from Form 8-K (Exhibit 2.2), filed 06/16/22, SEC File No.
−Removed: Amended and Restated Bylaws of Co-Diagnostics, Inc.
−Removed: (Incorporated by reference herein from Form 8-K (Exhibit 3.1), filed 04/01/22, SEC File No.
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
15 unchanged sentences
CO-DIAGNOSTICS,
−Removed: August 11, 2022
+Added: November 10, 2022
Executive Officer, President and Principal Executive Officer
−Removed: August 11, 2022
+Added: November 10, 2022
Financial Officer and Principal Financial and Accounting Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.